Needle-free Injection Systems Market Size to reach $24.9 billion by 2023

Wednesday 14 February 2018, Amsterdam

According to a new report Global Needle-free Injection Systems Market, published on ASDReports.com, the Global Needle-free Injection Systems Market size is expected to reach $24.9 billion by 2023, rising at a market growth of 17.4% CAGR during the forecast period.

The Fillable Needle-Free Injectors market holds the largest market share in Global Needle-free Injection Systems Market by Product in 2016, and would continue to be a dominant market till 2023. The Prefilled Needle-Free Injectors market is expected to witness a CAGR of 18.7% during (2017 – 2023). The Fillable Needle-Free Injectors market would attain market value of $13,697.0 million by 2023.

The North America market holds the largest market share in Global Spring-Based Needle-Free Injectors Market by Region in 2016, and would continue to be a dominant market till 2023; growing at a CAGR of 17.6 % during the forecast period.

The Europe market is expected to witness a CAGR of 17.2% during (2017 – 2023) in Global Gas Propelled/ Air Forced Injector Systems Market. Additionally, The Asia Pacific market is expected to witness a CAGR of 17.1% during (2017 – 2023).

The Powder-Based Needle Free Injectors market holds the largest market share in Global Needle-free Injection Systems Market by Type in 2016, and would continue to be a dominant market till 2023; growing at a CAGR of 16.7 % during the forecast period. The Projectile/Depot-Based Needle-Free Injectors market is expected to witness a CAGR of 17% during (2017 - 2023). Additionally, The Liquid-Based Needle Free Injectors market is expected to witness a CAGR of 18.9% during (2017 – 2023).

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the Global Needle-free Injection Systems Market have been discussed in the report with the elaborated company profiles of Endo International PLC, Antares Pharma, Inc, Pharmajet, Medical International Technology, Inc. (MIT), Injex Pharma AG, National Medical Products, Inc., Valeritas, Inc., European Pharma Group BV, Wright Medical Group, Inc., and Bioject Medical Technologies Inc.